Companies that disclose their R&D activities in annual reports enhance predictability of future performance for investors, despite inherent uncertainties in related expenditure.
Growth-stage fundraising is evolving, with a focus on adapting to new challenges. Cathy Gao emphasizes that understanding investor perspectives and sharpening pitches is critical in this competitive market.